Source: BioPortfolio

Intellect Neurosciences: Intellect Neurosciences Inc ILNS Financial and Strategic SWOT Analysis Review Updated 13012017 Prices from USD $300

SummaryIntellect Neurosciences Inc Intellect Neuro is a biopharmaceutical company that discovers and develops therapeutic products for the treatment and prevention of Alzheimer's disease and other serious neurological disorders. The company's internal dru...

Read full article »
Intellect Neurosciences's Competitors | Intellect Neurosciences's News | Intellect Neurosciences's Financials
Stay up-to-date with the latest news on Intellect Neurosciences
Annual Revenue
$5.0-25M
Employees
25-100
Elliot M. Maza's photo - Chairman & CEO of Intellect Neurosciences

Chairman & CEO

Elliot M. Maza

CEO Approval Rating

68/100

Read more
Stay up-to-date with the latest news on Intellect Neurosciences